Given these findings, it is plausible to infer that the inflammatory processes associated with GPP, mediated by IL-36 and IL-17, may extend beyond mere skin inflammation to significantly contribute to the higher prevalence of osteoporosis observed in these patients. The gene discussed is IL17A; the disease is osteoporosis.